NCT00405327 A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00392340 Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma Status UNKNOWN Phase PHASE2
NCT00389766 High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma Status WITHDRAWN Phase PHASE2
NCT00365755 Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma Status COMPLETED Phase PHASE3
NCT00357500 Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer Status COMPLETED Phase PHASE2
NCT00349024 Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer Status UNKNOWN Phase NA
NCT00336531 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE4
NCT00324324 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Status TERMINATED Phase PHASE3
NCT00311584 Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma Status COMPLETED Phase PHASE2
NCT00303940 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00295919 N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma Status COMPLETED Phase PHASE1
NCT00293384 Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant Status COMPLETED Phase NA
NCT00293319 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma Status COMPLETED Phase PHASE2
NCT00287950 Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma Status UNKNOWN Phase NA
NCT00281905 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Status UNKNOWN Phase PHASE2
NCT00276731 Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma Status UNKNOWN Phase PHASE3
NCT00276679 Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma Status COMPLETED Phase PHASE2
NCT00253435 N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma Status COMPLETED Phase PHASE2
NCT00206388 Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement Status COMPLETED Phase PHASE1
NCT00202930 Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma Status TERMINATED Phase PHASE2